DB
IART icon

Dmitry Balyasny’s Integra LifeSciences IART Stock Holding History

Dmitry Balyasny’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Sell
640,666
-53,410
-8% -$747K 0.01% 995
2026
Q1 		$6.54M Buy
694,076
+557,791
+409% +$6.12M 0.01% 1246
2025
Q4 		$1.69M Buy
136,285
+111,165
+443% +$1.48M ﹤0.01% 1952
2025
Q3 		$360K Buy
+25,120
New +$344K ﹤0.01% 2516
2024
Q4 		– Sell
-614,682
Closed -$11.2M – 2974
2024
Q3 		$11.2M Buy
+614,682
New +$14.2M 0.02% 890
2024
Q2 		– Sell
-208,681
Closed -$7.4M – 2809
2024
Q1 		$7.4M Buy
208,681
+163,982
+367% +$6.56M 0.01% 1066
2023
Q4 		$1.95M Buy
44,699
+14,583
+48% +$574K ﹤0.01% 1460
2023
Q3 		$1.15M Sell
30,116
-215,455
-88% -$9.06M ﹤0.01% 1534
2023
Q2 		$10.1M Buy
245,571
+163,649
+200% +$7.88M 0.02% 773
2023
Q1 		$4.7M Buy
81,922
+49,386
+152% +$2.78M 0.01% 1104
2022
Q4 		$1.82M Sell
32,536
-179,540
-85% -$9.14M 0.01% 1460
2022
Q3 		$8.98M Buy
+212,076
New +$10.9M 0.03% 736
2021
Q2 		– Sell
-79,423
Closed -$5.49M – 2131
2021
Q1 		$5.49M Buy
+79,423
New +$5.38M 0.03% 666
2019
Q3 		– Sell
-32,841
Closed -$1.83M – 1357
2019
Q2 		$1.83M Buy
32,841
+11,577
+54% +$596K 0.01% 895
2019
Q1 		$1.19M Buy
+21,264
New +$1.08M 0.01% 965
2018
Q3 		– Sell
-3,489
Closed -$225K – 1832
2018
Q2 		$225K Buy
+3,489
New +$216K ﹤0.01% 1607
2015
Q3 		– Sell
-8,147
Closed -$224K – 1250
2015
Q2 		$224K Buy
+8,147
New +$217K ﹤0.01% 1001

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dmitry Balyasny's IART Position: Q2 2026 in Review

Dmitry Balyasny reduced its Integra LifeSciences (IART) stake by 7.7% in Q2 2026, selling an estimated $747K and leaving 640,666 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #995.

Dmitry Balyasny first reported a position in IART in Q2 2015 and has held it in 17 quarters since. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Dmitry Balyasny held 640,666 shares of Integra LifeSciences worth $11.5M as of Q2 2026.
  • Dmitry Balyasny sold 53,410 Integra LifeSciences shares in Q2 2026, an estimated $747K.
  • Integra LifeSciences made up 0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #995 holding.
  • Dmitry Balyasny first reported a position in Integra LifeSciences in Q2 2015 and has held it in 17 quarters since.
  • 211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.